Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Ricardo Chaves, n/a
Debiopharm International, Switzerland
Poster(s):
(P-65) Results from A Phase 2 Clinical Trial for Treatment of Bone And Joint Infections with Afabicin, A First-in-Class Selective Anti-Staphylococcal Antibiotic
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-1830) The First-in-Class Anti-Staphylococcal Antibiotic Afabicin Desphosphono is Not Associated With
Clostridioides difficile
Infection in an in vitro Human Gut Model
Saturday, October 19, 2024
12:15 PM – 1:30 PM
US PT